suramin has been researched along with ovalbumin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, EH; Huang, G; Shi, Y; Song, Y; Su, X; Xin, XF; Zhang, F | 1 |
Hara, Y; Kawada, A; Matsuo, K; Mishima, I; Nakayama, T; Oiso, N; Sakai, S; Yamamoto, S; Yoshie, O | 1 |
2 other study(ies) available for suramin and ovalbumin
Article | Year |
---|---|
Adenosine Triphosphate Promotes Allergen-Induced Airway Inflammation and Th17 Cell Polarization in Neutrophilic Asthma.
Topics: Adenosine Triphosphate; Allergens; Animals; Apyrase; Asthma; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neutrophils; Ovalbumin; Pneumonia; Purinergic P2 Receptor Antagonists; Receptors, Antigen, T-Cell, alpha-beta; Suramin; T-Lymphocyte Subsets; Th17 Cells | 2017 |
P2X receptor agonist enhances tumor-specific CTL responses through CD70+ DC-mediated Th17 induction.
Topics: Adenosine Triphosphate; Adjuvants, Vaccine; Animals; CD27 Ligand; Cell Differentiation; Dendritic Cells; Disease Models, Animal; Immunization; Intestinal Mucosa; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Ovalbumin; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X; Suramin; T-Lymphocytes, Cytotoxic; Th17 Cells | 2021 |